Advertisement

PHAS

PhaseBio Pharmaceuticals, Inc.

Set alert

Price alert · PHAS

All alert types
0.07 0.00 0.00%
As of Nov 2, 2022
0.0665 Day range 0.092

52-week range unavailable

Open
0.0807
Prev close
0.0701
Mkt cap
0
Vol
8.60M
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
0.0665
High
0.092
Forward P/E
0.00
Beta
0.00
Dividend
0.00
Ex-div date
Earnings
Nov 9, 2022
50-d avg
0.00
200-d avg
0.00
1y target
1.00

2Y chart

Chart tools
Interval

Chart is warming up

The two-year price history for PHAS has not been loaded yet. Try again in a moment.

Key statistics

Market cap
0
Trailing P/E
0.00
Forward P/E
0.00
Price / sales
0.00
Beta
0.00
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
0.00%
Revenue (TTM)
0
Revenue growth
0.00%
Free cash flow
0
Total cash
0
Total debt
0
Return on equity
0.00%
50-day average
0.00
200-day average
0.00

Analyst view

Consensus: hold

Hold
Price target (mean) 1.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
  • Strong buy2
  • Buy2
  • Hold0
  • Sell0
  • Strong sell0

Next earnings

Nov 9, 2022

Expected Nov 9, 2022. Consensus EPS estimate -0.35.

Earnings history

Earnings

PHAS recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 9, 2022Sep 1, 20220.00———
Aug 12, 2022Jun 1, 2022-0.33———
May 16, 2022Mar 1, 2022-0.67———
Mar 24, 2022Dec 1, 2021-0.39———
Nov 10, 2021Sep 1, 2021-0.62———
Aug 12, 2021Jun 1, 2021-0.60———

Upgrades / downgrades

PHAS analyst upgrades and downgrades
DateFirmActionFromTo
Oct 23, 2022Cowen & Co.downOutperformMarket Perform
Sep 27, 2022William BlairdownOutperformMarket Perform
Sep 27, 2022NeedhamdownBuyHold
Aug 14, 2022Needhammain—Buy
Mar 27, 2022Needhammain—Buy
Jun 16, 2021Needhammain—Buy

News

Your note

Sign in to keep a note on PHAS — it syncs with the Stock Master app.

Insider holders

PHAS insider holders
InsiderRelationLatest transactionDateShares held
ARNOLD SUSAN ELIZABETHOfficerStock Award(Grant)May 19, 202241,236
BIRCHALL JONATHANOfficerStock Award(Grant)May 19, 202220,000
BURKHARDT GLENOfficerSaleMay 22, 20220
HANSON KRISTOPHERGeneral CounselStock Award(Grant)May 19, 20228,463
HUTSON NANCY JDirectorConversion of Exercise of derivative securityNov 7, 202133,760
MOW JONATHAN P.Chief Executive OfficerStock Award(Grant)May 19, 2022183,701

Institution ownership

PHAS institution ownership
Holder% heldSharesValueReported
NEA Management Company, LLC13.33%6,643,7023.99MJun 29, 2022
Avidity Partners Management, LP8.84%4,405,0002.64MJun 29, 2022
Rock Springs Capital Management, LP5.57%2,774,8691.66MJun 29, 2022
Vanguard Group, Inc. (The)3.63%1,808,0981.08MJun 29, 2022
MAI Capital Management3.43%1,709,1041.03MJun 29, 2022
Johnson & Johnson3.22%1,607,044964.07KJun 29, 2022

Fund ownership

PHAS fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund2.32%1,156,526693.80KJun 29, 2022
Vanguard Extended Market Index Fund1.09%545,560327.28KJun 29, 2022
Fidelity Extended Market Index Fund0.34%167,383100.41KJun 29, 2022
Bridgeway Funds Inc-Ultra Small Company Market Fund0.24%120,00071.99KJun 29, 2022
iShares Micro Cap ETF0.15%73,50512.94KSep 29, 2022
Fidelity NASDAQ Composite Index Fund0.14%69,13241.47KJun 29, 2022
Advertisement